tiprankstipranks
Trending News
More News >
Arcutis Biotherapeutics (ARQT)
NASDAQ:ARQT
US Market
Advertisement

Arcutis Biotherapeutics (ARQT) Similar Stocks

Compare
924 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Arcutis Biotherapeutics
$19.64
$2.41B
186.45%
6 Buy
0 Hold
0 Sell
Strong Buy
Travere Therapeutics
$29.81
$2.66B
-14.61
66.72%
14 Buy
2 Hold
0 Sell
Strong Buy
Disc Medicine
$87.61
$3.20B
89.67%
11 Buy
0 Hold
0 Sell
Strong Buy
Harmony Biosciences Holdings
$30.11
$1.74B
9.71
-17.09%
9 Buy
0 Hold
1 Sell
Strong Buy
Tarsus Pharmaceuticals
$68.16
$2.79B
70.31%
6 Buy
0 Hold
0 Sell
Strong Buy
Recursion Pharmaceuticals
$6.30
$2.63B
-12.31%
1 Buy
4 Hold
0 Sell
Hold

Performance Comparison

Ticker
Company Name
Price
Change
% Change
ARQT
Arcutis Biotherapeutics
24.95
16.39
191.47%
TVTX
Travere Therapeutics
29.81
11.44
62.28%
IRON
Disc Medicine
87.61
41.71
90.87%
HRMY
Harmony Biosciences Holdings
29.64
-11.85
-28.56%
TARS
Tarsus Pharmaceuticals
67.56
23.69
54.00%
RXRX
Recursion Pharmaceuticals
5.91
-0.83
-12.31%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis